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HIV-related Stigma and Health among People Living with HIV in Middle Georgia: 
 
Examining the Roles of Stress and Coping 
 
Kaylee E. Burnham, Ph.D. 
 
University of Connecticut, 2017 
 
 
Objective – HIV-related stigma and discrimination are drivers of health disparities 
among people living with HIV (PLWH). The U.S. South bears much of the burden of the 
domestic HIV epidemic. This study seeks to explore the dynamic effects of HIV-related 
stigma on health outcomes in a population of PLWH in middle Georgia. Experiences of 
enacted HIV stigma in the past year were assessed and participants indicated how 
stressful these events were and how they coped with the most impactful event. The 
primary study aim tested a moderated serial mediation model of HIV stigma on health in 
this population.  
Method – A total of 199 people living with HIV completed surveys via audio computer-
assisted self-interviews (ACASI) while they attended their regular clinic appointment at a 
Ryan White clinic located in Macon, GA. Measures included demographics, health 
information, experiences of enacted stigma in the past year, stress and coping with the 
most impactful enacted stigma event. Medical information (viral load, CD4 count, clinic 
attendance, and medications) was abstracted from patient charts for a period of 6 
months prior to their survey date. 
Results – A total of 96 individuals endorsed experiencing enacted stigma in the past 
year, and the sample endorsed moderate levels of internalized HIV stigma. Individuals 
who endorsed enacted stigma tended to have more negative psychosocial and mental 
health outcomes. Internalized stigma related to stress indexed on the most salient event  
Kaylee E. Burnham – University of Connecticut, 2017 
 
of enacted stigma in the past year as well as maladaptive coping strategies used to 
cope with discriminatory experiences. There was not evidence in multivariate analyses 
that stress or maladaptive coping mediated effects of internalized stigma on medication 
adherence. There was also not a moderating effect of adaptive coping strategies on 
medication adherence in this sample. 
Conclusion – HIV stigma appears to have short-term effects on mental health, which 
could lead to long-term effects on physical health. Longitudinal investigations are 
indicated to uncover the mediating and attenuating mechanisms of HIV stigma on health. 
Stigma should be addressed in the context of health promotion interventions for PLWH 
given its implications on mental health and wellbeing.  
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HIV-related Stigma and Health among People Living with HIV in Middle Georgia:  
Examining the Roles of Stress and Coping 
 
 
Addressing health disparities faced by individuals living with human 
immunodeficiency virus (HIV), including HIV-related stigma is a public health priority. 
HIV stigma – defined as the social devaluation and discrediting of people living with HIV 
(PLWH) – is a significant barrier to improving the health and wellbeing of PLWH (Link & 
Phelan, 2001; Mahajan, et al., 2008; Hatzenbuehler, Phelan, and Link, 2013). Stigma 
produces limitations across all levels of prevention and management of HIV. 
Consequences of HIV stigma include reduced uptake of HIV-related information and 
testing, lower linkage and retention in HIV care, lower treatment adherence, accelerated 
HIV disease progression, poorer mental health, lower likelihood of HIV status disclosure, 
and rejection and isolation from family, friends, and community supports (Fife & Wright, 
2000; Herek, Capitanio, & Widaman, 2003; Vanable, Carey, Blair, & Littlewood, 2006; 
Logie & Gadalla, 2009; Katz, et al., 2013; Earnshaw, Smith, Chaudoir, Amico, & 
Copenhaver, 2013). Stigma functions as a chronic stressor in the lives of those who are 
stigmatized, serving as a mechanism that undermines health and drives health 
inequalities (Phelan, Link, & Tehranifar, 2010). Recently, the National AIDS Strategy 
(2015) called for the reduction of HIV stigma as a means to improve health among 
PLWH:  
“The United States will become a place where new HIV infections are rare, and 
when they do occur, every person, regardless of age, gender, race/ethnicity, 
sexual orientation, gender identity or socio-economic circumstance, will have 
unfettered access to high quality, life-extending care, free from stigma and 
discrimination.” (White House Office of National AIDS Policy, 2015, p.3) 
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However, stigma has proven difficult to reduce and eliminate at the societal and 
structural level. Theoretical and meta analytic work suggests the importance of 
understanding the dynamic effects of HIV stigma on individuals, and finding avenues to 
protect people from the harmful impact of stigma (e.g., Earnshaw, Lang, Lippitt, Jin, & 
Chaudoir, 2015; Earnshaw, Bogart, Dovidio, & Williams, 2013; Logie & Gadalla, 2009).  
 
Defining Stigma and Its Mechanisms 
Early research on HIV stigma was built on Erving Goffman’s (1963) 
conceptualization of stigma that characterized people with an “attribute that is deeply 
discrediting” (p.3). Note that Goffman’s writing was published well before the onset of 
the HIV epidemic in the 1980’s, and he focused his conceptualization on those with a 
visible “identity,” which allowed observers to link the attribute to stereotypes (Jones, et 
al., 1984). Stigma is a complex phenomenon and there remains some variation in how it 
is defined and conceptualized. To the preceding definition, Link and Phelan (2001) 
added important components of stigma: that it leads to a degree of separation between 
“us” (the stigmatizers) and “them” (the stigmatized), and that identification of a 
stigmatized trait leads to status loss and adverse outcomes. Discrimination, prejudice, 
and stereotyping encompass behavioral, affective, and cognitive responses that occur 
as a result of a more global stigma process (Deacon, 2006). Applied to the HIV 
epidemic, this process likely occurs as a means for people to distance themselves from 
risk of infection by blaming and marginalizing other groups for contracting and 
spreading the disease (e.g., people who engage in risky sexual behaviors, sex workers, 
gay and bisexual men, transgender individuals, IV drug users, people living in poverty, 
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racial minorities, women).  Moreover, this process of stigmatization and discrimination 
occur in the context of a structure of social and economic power (Link & Phelan, 2001; 
Mahajan, et al., 2008). From a sociological perspective, “stigma and stigmatization 
function – quite literally – at the intersection of culture, power, and difference” (Parker & 
Aggleton, 2003, p.17). As such, HIV stigma often occurs in tandem with other socially 
devalued characteristics (e.g., socioeconomic status, race, gender, sexual orientation; 
Parker & Aggleton, 2003). These aforementioned perspectives offer context to the 
problem of HIV stigma as a social process, but additional work is needed to understand 
how stigma impacts individuals.  
Earnshaw and Chaudoir (2009) synthesized the literature on stigma’s impact on 
individuals by reviewing HIV stigma measures. They found three distinct mechanisms of 
HIV-related stigma conceptualized in their model, the HIV Stigma Framework. Enacted 
stigma (also referred to as perceived stigma) is the prejudice and discrimination from 
others that are experienced by PLWH. Anticipated stigma describes expectations that 
PLWH have that they will be discriminated against because of their HIV status. 
Internalized stigma (also referred to as self stigma) refers to the extent to which PLWH 
apply negative beliefs and feelings about HIV/AIDS to themselves. Since their review, 
Earnshaw and colleagues (2013) hypothesized and tested potential relationships 
between the HIV stigma mechanisms and health outcomes. For instance, enacted 
stigma demonstrates greater association with physical health outcomes (e.g., CD4 cell 
count). Anticipated stigma is associated with adverse behavioral outcomes such as 
lower engagement in medical care. Internalized stigma is associated with negative 
emotional states (e.g., helplessness).  In their review, Earnshaw and Chaudoir (2009) 
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pointed to the importance of building an understanding of who is affected by HIV stigma, 
how they are affected, and what the outcomes of HIV stigma mechanisms are at the 
individual level as a way to study this complex construct moving forward. 
 
Stigma and Health 
As the concept of stigma has evolved, researchers are increasingly interested in 
explaining and quantifying its impact on health. A major body of work in this field has 
introduced and investigated the minority stress model. This model implies causal 
relationships between sexual minority group status, increased stress, limited coping 
resources, and adverse health outcomes, including HIV risk (Meyer, 1995). A separate 
literature has investigated the implications racism and race-related discrimination on 
health (e.g., Brondolo, Brady, Pencille, Beatty, & Contrada, 2009). Moreover, stigma 
has become a focus in the area of HIV behavioral research (Earnshaw, et al., 2013; 
Rueda, et al., 2016). Despite these relatively separate tracks of research, they share 
commonalities in that the models define stigma and discrimination as stressors in the 
lives of those who experience them. They also promote coping resources as buffers to 
the effects of stigma that drive health disparities. Regardless of stigmatized 
characteristic, Hatzenbuehler, Phelan, and Link (2013) recommend the synthesis of 
models of health disparities for members of stigmatized groups to better understand 
stigma as a social determinant of health. 
Some more comprehensive models have grown out of the literature that may 
explain some of the dynamic processes of stigma and its impact on health. Pascoe and 
Richman (2009) proposed a conceptual model, which they supported with a meta-
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analysis to describe how perceived discrimination affects physical and mental health 
outcomes. Perceived discrimination in their model maps well onto the construct of 
enacted stigma. In Pascoe and Richman’s model, discrimination is conceptualized as a 
social stressor that affects health through the mechanism of physical or psychological 
stress responses, as well as engagement in negative health behaviors (or conversely, 
the lack of engagement in positive health behaviors).  
Stigma and stress. Among PLWH, stress can impact HIV disease progression 
and it has been associated with lower CD4 cell counts (Leserman, 2003). Stress is an 
important variable to monitor in PLWH as it can impede immune functioning and 
interfere with achievement of viral suppression. 
From a mechanistic perspective, there are a few different ways stigma functions 
as a stressor. Enacted stigma is often explicit interpersonal exclusion that is 
unpredictable and uncontrollable. Given the ambiguousness that sometimes underlies 
discriminatory experiences, people may have difficulty identifying the stressor and 
deciding on an appropriate coping response (Williams, Neighbors, & Jackson, 2003). 
Exposure to discrimination has been linked to physiological responses characteristic of 
a stress response including increased heart rate, increased blood pressure, and 
elevated cortisol levels (e.g., Clark, Anderson, Clark, & Williams, 1999). Pascoe and 
Richman recommended future investigation of chronic and recent events of 
discrimination that appear to have the most deleterious effect on health. Moreover, the 
mediated relationship of enacted stigma to physical health via stress may occur as 
individuals increasingly experience stigmatizing events. With increasing exposure to 
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stigma, physiological and psychological stress responses are activated and can lead to 
a chronic negative emotional state (Pascoe & Richman, 2009).  
Anticipated stigma functions somewhat differently as a stressor. Instead of being 
marked by events of exclusion, anticipated stigma creates vigilance to negative 
treatment by others. This leads to a chronically aroused state that can deteriorate 
coping resources over time (Stuber, Meyer, & Link, 2008). Indeed, individuals living with 
chronic illnesses who report high levels of anticipated stigma also report high levels of 
perceived stress that impacts their quality of life (Earnshaw, Quinn, & Park, 2012).  
Internalized stigma creates stress through the process of ongoing cognitive 
appraisals of negative societal attitudes applied to oneself. Internalized stigma has been 
associated with greater psychological distress (Ross & Rosser, 1996; Boone, Cook, & 
Wilson, 2016). Furthermore, individuals with internalized stigma are likely more 
sensitive to anticipated and enacted stigma (Chesney & Smith, 1999), and they likely 
have fewer interpersonal resources to cope (Helms, et al., 2016). 
Coping with Stigma. Researchers hypothesize that coping resources buffer 
against the potentially negative effects of enacted stigma on health (Pascoe & Richman, 
2009; Earnshaw, et al., 2015). In their meta-analytic review, Pascoe and Richman 
(2009) hypothesized about the role of coping resources in buffering the impact of 
enacted stigma on health. Similarly, Earnshaw, and colleagues (2013) indicated the 
need to investigate strength-based, modifiable resources that may moderate the effect 
of stigma on health outcomes. Few studies in the area of HIV have looked at specific 
coping strategies PLWH use to manage their experiences of HIV stigma. Varni, et al. 
(2012) examined the role of engagement and disengagement coping strategies on 
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depression, anxiety, and self-esteem among PLWH. Their findings suggested that 
engagement coping attenuated the relationship between stigma and self-esteem. Social 
support, the tangible and emotional support offered by others, is a promising resource 
for individuals facing stigma. Social support has demonstrated buffering effects on 
health in the more global health literature (Cohen, 2004). Seeking social support may 
help people regulate their emotions and problem solve under stress related to stigma 
(Earnshaw, et al., 2013). Results on the effect of social support as a coping resource 
have been mixed with some finding evidence that social support serves as a moderator 
and some finding no effect of social support (e.g., Earnshaw, et al., 2015; Logie, et al., 
2012). Additional research is needed to determine the existence and magnitude of 
these relationships, and should also account for a variety of different coping strategies 
such as seeking other supportive resources (e.g., religion), and use of cognitive coping 
strategies (e.g., acceptance). 
Maladaptive or avoidant coping strategies should also be addressed, particularly 
given the uncontrollable nature of stigma. Previous research suggests that individuals 
may engage in negative health behaviors like alcohol use as a means to escape the 
negative emotional and cognitive experiences associated with stigma (Pascoe & 
Richman, 2009). Given the stress and coping framework, maladaptive coping strategies 
like substance use become available when adaptive coping resources become 
overwhelmed by stress (Litt, Kadden, & Kabela-Cormier, 2009). Furthermore, high 
levels of disengagement coping have been associated with higher levels of anxiety and 
depression among PLWH reporting experiences of enacted stigma (Varni, et al., 2012), 
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creating a problematic cycle between distress and avoidance. These maladaptive or 
avoidant coping strategies may complicate clinical outcomes for PLWH.  
 
Health outcomes pertinent to PLWH. Health outcomes among people living with 
HIV are evaluated along the HIV treatment cascade, or care continuum (Gardner, et al., 
2011; Mugavero, et al., 2013). The continuum monitors the proportion of PLWH who are 
connected to testing resources and diagnosed; the number of people diagnosed who 
are linked to medical care; the number of people who remain engaged in their medical 
care; as well as the number of people prescribed antiretroviral treatment (ART). For 
individuals who are engaged in care and taking ART, the optimal outcome is HIV viral 
suppression, which reflects antiretroviral medication adherence. Adherence to ART and 
viral suppression improve the health of PLWH and significantly reduce the likelihood of 
HIV transmission (Cohen, et al., 2011). However, only about 30% of individuals who are 
living with HIV are virally suppressed according to estimates by the Centers for Disease 
Control (Bradley et al., 2014). This indicates the importance of psychosocial and 
behavioral factors that interfere with PLWH achieving optimal health. As stated in the 
National HIV/AIDS Strategy (2015), Americans with the least access to prevention and 
treatment services are those most affected by HIV. The writers further pointed to the 
management of stigma as one means to end these disparities.  
The literature that links stigma to health outcomes has steadily grown over recent 
years. A meta-analysis of 24 studies indicated that HIV stigma is associated with 
negative mental and physical health outcomes including increased depression and 
greater evidence of HIV disease progression (Logie & Gadalla, 2009). Katz and 
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colleagues (2013) reviewed and meta-synthesized 75 quantitative and qualitative 
studies finding stigma as an inhibitor to ART adherence. Despite the growth of 
academic inquiry in this area, relatively little is known about the mechanisms that 
explain the relationship between stigma and health in the HIV literature (Rueda, et al., 
2016). Rao and colleagues (2012) found that depressive symptoms partially mediate 
the relationship between HIV-related stigma and medication adherence. Another group 
of researchers found mediating effects of interpersonal factors on the relationship 
between stigma and medication adherence (Helms, et al., 2016). No studies to our 
knowledge have explicitly examined the roles of stress related to stigma and coping with 
enacted stigma in relationship to medication adherence or other health outcomes. 
In the consideration of overall health and wellbeing among PLWH, co-occurring 
chronic and acute conditions should be considered in the management of HIV-related 
health. Mixed results have been found regarding the burden of co-morbid health 
conditions and retention in medical care (Corless, et al., 2008; Crawford, 2015). Some 
researchers have linked co-morbid health conditions and polypharmacy with lower ART 
adherence (Krentz & Gill, 2016). Examining co-occurring medical needs may be 
important for the assessment of health among PLWH, and a potential addendum to the 
HIV treatment cascade. 
 
The HIV Epidemic in the State of Georgia 
The Southern region of the United States is an important area for research related to 
HIV-related stigma and health. The incidence of new HIV diagnoses as of 2014 was the 
highest in the South with a rate of 18.5 per 100,000 people (for comparison the national 
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rate was 13.8 per 100,000 people; CDC, 2016). Not only are more people living with 
HIV in the South, more people are progressing to diagnoses of AIDS and dying from 
AIDS (CDC, 2015a). Considering the treatment options that are available to PLWH, 
these disparities must be considered in light of social determinants.  
The state of Georgia ranked fifth out of the 50 states in the U.S. in the number of 
adults living with HIV in 2013 (CDC, 2015b). While over 60% of HIV cases are localized 
to the Atlanta and metropolitan-Atlanta area, rates of HIV in other health districts are 
significant given the population distribution in those areas. As of 2014 (the latest year 
for which data are available), the rate of PLWH in the North Central (Macon) area was 
406 per 100,000 persons; the rate of HIV infection in the state of Georgia was 527 per 
100,000 persons (Georgia Department of Public Health, 2016).  
In Georgia, there are few resources for PLWH outside of the metro Atlanta area. 
Stigma is a high risk for individuals diagnosed with HIV living in suburban and rural 
Georgia with sparse opportunities for support. Furthermore, little research has been 
carried out on the experiences of stigma and health among PLWH who reside in middle 
Georgia. This represents a novel population for which it is important to investigate how 
HIV stigma may act as a barrier to health.  
 
Current Study 
The purpose of the present study is to build on the existing literature about the 
experience of HIV stigma and its relationship to health among PLWH living in the 
southern United States and to explore potential mechanisms of that complex 
relationship. The first research question aims to answer whether there is a direct 
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relationship between internalized HIV stigma and health. Consistent with models of 
stigma and discrimination on health, a negative relationship between internalized HIV 
stigma and HIV-related health outcomes is expected, such that participants who 
endorse higher levels of stigma will have lower medication adherence, and be less likely 
to be virally suppressed.  
The next research questions will address potential mediating effects of 
internalized HIV stigma, including stress and maladaptive coping strategies. It is 
expected that both the stress associated with enacted stigma and maladaptive 
strategies for coping with events of enacted stigma will strengthen the relationship 
between internalized HIV stigma and negative health outcomes. The final research 
question will assess the potential moderating effect of adaptive coping responses such 
as acceptance, seeking social support, and spiritual coping. It is expected that adaptive 
coping resources will buffer the relationship between HIV stigma and HIV-related health 
outcomes. The proposed model illustrating these hypothesized relationships is depicted 
in Figure 1. Overall, the current study seeks to understand mechanisms of HIV-related 
stigma on health within a stress and coping framework. 
 
Methods 
Participants and Procedures 
 Participants were recruited from a Ryan White funded clinic located in Macon, 
GA between February and May 2016. To be included in the study, participants had to 
be 1) 18 years or older, 2) able to understand all study procedures and provide informed 
consent, 3) HIV-positive, and 4) a clinic patient attending an initial or update 
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appointment. Patients were approached by a research staff member in the clinic waiting 
area and informed about the opportunity to participate in the study. To reduce any 
pressure on patients to participate in the clinic survey, no clinic staff members were 
involved in recruiting participants. If a patient expressed interest, they were provided an 
e-tablet with headphones that administered the consent form via audio-computer 
assisted self-interview (ACASI). After reading and/or listening to the consent form 
participants were invited to ask any questions and then signed a consent form if they 
agreed to the study procedures. A total of 258 people were approached, 58 individuals 
refused to participate, and 199 patients agreed to complete study procedures (77%). 
Following consent, participants were again provided with an e-tablet with 
headphones and completed their ACASI survey that was de-identified with a participant 
identification number. The survey took approximately 30 minutes to complete. 
Participants were each compensated for their time with a $15 gift card.  
As part of informed consent, participants provided release of information to 
access health information from their electronic medical record including clinic 
attendance, viral load, CD4 count, and medications inclusive of the date of their current 
appointment to six months prior. Medical data were collected through retrospective 
chart review, linked by date of birth. No other identifying information was collected. 
Research staff collected and coded chart data. No clinic staff members were involved in 
chart data collection to protect participant privacy. The University of Connecticut and the 
Mercer University Institutional Review Boards approved all study procedures. In addition, 
a Certificate of Confidentiality was sought to protect participants’ information. 
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Self-Report Measures 
Socio-demographic Information. Participants were asked their age, self-
identified gender, race, sexual orientation, education attainment, employment status, 
religion, and history of incarceration. Indicators of poverty were assessed including 
availability of transportation, housing security, and food sufficiency in the past month.  
Health Information. Health information including the date of their first HIV 
antibody test, whether they are currently taking antiretroviral medications, and questions 
about their antiretroviral medication adherence, including a visual analog scale (VAS) of 
adherence in the past month, were asked. We dichotomized self-reported medication 
adherence as adherent (reported 85% on VAS) and non-adherent (<85% on VAS). 
Questions were also asked to assess whether participants hid their antiretroviral 
medications (e.g., physically hide medications, take medications out of their bottles, tell 
people medications are for something else). Service utilization was assessed including 
attendance to a mental health counselor, substance use counselor, HIV support group, 
and/or Alcoholics Anonymous/Narcotics Anonymous group in the past month. 
Health-related quality of life (HRQL) was also assessed using items from the 
Center for Disease Control and Prevention’s Behavioral Risk Factor Surveillance 
Survey health-related quality of life items (CDC, 2000). These items included 
assessment of general health status, number of days in the past month that physical 
health was not good, number of days in the past month when activity was limited as a 
result of physical health, number of days in the past month when pain was present, and 
number of days in the past month when health was good. 
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Depressive symptoms were assessed using the Center for Epidemiological 
Studies - Depression Scale (CES-D; Radloff, 1977). The CES-D includes 20 items 
assessing cognitive, affective, and vegetative symptoms of depression. Radloff (1977) 
suggested a clinical cutoff of 16 to indicate possible depression, or a stricter cutoff of 23 
to indicate probable depression. Reliability of the CES-D was good in the current 
sample (Cronbach’s alpha = .889). In accordance with Kalichman, Rompa and Cage’s 
(2000) findings that somatic symptoms on the CES-D may be explained by HIV 
symptoms, the cognitive/affective item score on the CES-D was also calculated and had 
acceptable internal consistency (Cronbach’s alpha=.798).  
Alcohol use and symptoms of alcohol dependence were assessed with the 
Alcohol Use Disorder Identification Test (AUDIT; Saunders, et al., 1993; Schmidt, Barry 
& Fleming, 1995). The AUDIT, developed by the World Health Organization (WHO), 
includes 10 items used to assess alcohol use and problematic behaviors resultant of 
alcohol use. A cutoff score of 8 or above is suggested to identify individuals who have 
problematic patterns of alcohol use. Participants skipped out of the last 9 questions of 
the measure if they reported they do not drink any alcohol on the first question, which 
assesses alcohol consumption. This scale also showed good internal consistency in the 
present sample, Cronbach’s alpha = .847. In addition, participants were asked about 
their use of drugs in the past month including marijuana, cocaine, and any other drug 
without a prescription. 
Internalized HIV Stigma. The HIV Stigma Mechanisms Scale (Earnshaw, et al., 
2013), internalized stigma subscale (6 items) was used to assess internalized HIV 
stigma. Participants responded to items assessing their negative feelings about living 
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with HIV (e.g., I feel ashamed about having HIV) on a Likert scale. Higher scores 
indicate greater internalized stigma (greater agreement with negative statements). In 
accordance with scoring procedures carried out by the scale authors, responses across 
the 6 items were averaged to create a composite score. Internal consistency of items in 
the subscale was very good in the present sample, Cronbach’s alpha = .914. 
Enacted HIV Stigma Checklist. Experiences of enacted HIV stigma (perceived 
discrimination) were assessed using 20 questions adapted from multiple enacted HIV 
stigma measures. Items were selected from the enacted stigma subscale of the HIV 
Stigma Mechanisms Scale (Earnshaw, et al., 2013), the HIV Stigma Scale (Bunn, et al., 
2007; Berger, et al., 2001), and the Multiple Discrimination Scale – HIV version (Bogart, 
Landrine, Galvan, Wagner, & Klein, 2013). Participants were asked about the frequency 
with which they experienced any of the items in the past year due to their HIV-positive 
status on a scale:  5 = almost everyday, 4 = at least once a week, 3 = a few times a 
month, 2 = a few times this year, 1 = about once this year, 0 = never. Responses across 
the 20 items were averaged to create a composite score. Reliability of items was very 
good in this sample, Cronbach’s alpha = .934. 
Stigma-Related Stress. For every item on the enacted HIV stigma checklist that 
participants endorsed occurring in the past year, they rated the negative impact (stress) 
that the event had on them. This involved asking one item for every enacted stigma 
event that a participant endorsed: “Please rate the level of negative impact this event 
had on you on a scale from 0 (no negative impact at all) to 10 (the most severely 
negative event you can imagine).” This stress item is adapted from the UCLA Life Event 
Stress Interview (Hammen, Adrian, Gordon, Burge, Jaenicke, & Hiroto 1987), which is 
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an interview schedule designed to assess chronic and acute life events/stressors. A 
composite stress score was calculated for each participant by averaging their stress 
scores across the 20 enacted stigma items. Participants’ stress rating on the most 
impactful enacted stigma event in the past year was used in multivariate analyses. 
Coping. The Brief COPE (Carver, 1997) was used to assess coping strategies 
used to deal with the most stressful experience of enacted HIV stigma in the past year. 
The Brief COPE is a 28-item, 14-scale measure of coping styles that was adapted from 
the original 60-item COPE (Carver, Scheier, & Weintraub, 1989), a validated measure 
of dispositional and situational coping. The 14 scales in the Brief COPE include Self-
distraction (“I've been turning to work or other activities to take my mind off things.”), 
Active coping (“I've been concentrating my efforts on doing something about the 
situation I'm in.”), Denial (“I've been refusing to believe that it has happened.”), 
Substance use (“I've been using alcohol or other drugs to make myself feel better.”), 
Use of Emotional Support (“I've been getting comfort and understanding from 
someone.”), Use of instrumental support (“I’ve been getting help and advice from other 
people.”), Behavioral disengagement (“I've been giving up trying to deal with it.”), 
Venting (“I've been saying things to let my unpleasant feelings escape.”), Positive 
reframing (“I've been looking for something good in what is happening.”), Planning (“I've 
been thinking hard about what steps to take”), Humor (“I've been making jokes about 
it.”), Acceptance (“I've been accepting the reality of the fact that it has happened.”), 
Religion (“I've been praying or meditating.”), and Self-blame (“I’ve been criticizing 
myself.”). Carver (1997) made no recommendations for categorizing coping styles (e.g., 
maladaptive vs. adaptive coping; problem-focused vs. emotion-focused) beyond the 
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individual scales on the Brief COPE, but did recommend creating higher order factors 
from one’s data (Carver, et al., 1989) if appropriate to the research question at hand. 
 Before beginning the Brief COPE, participants were first asked to choose which 
enacted stigma event out of those they endorsed in the past year had the most negative 
impact on them. They were then asked to think about the last time that event happened 
and what they did to cope with it, by rating items on the Brief COPE on a scale from 1 (I 
haven’t been doing this at all) to 4 (I’ve been doing this a lot). The Brief COPE was 
designed to concisely assess coping strategies related to a specific stressor, and it has 
been widely used in health populations, including PLWH (e.g., Turner-Cobb, et al., 
2002). Internal consistency of the Brief COPE was very good in the present sample, 
Cronbach’s alpha = .923 
 
Chart Abstracted Health Data  
Research staff abstracted medical information from patient charts, linked to study 
identification number by date of birth. Information abstracted ranged from the date of 
study survey over the six months prior. Viral load and CD4 cell counts were abstracted 
from participants’ medical charts to verify medication adherence and assess HIV 
disease progression. Viral suppression (undetectable viral load) was defined as viral 
load of less than 20 copies/ml, which is a sensitive threshold and how the clinic defined 
an undetectable viral load. A CD4 threshold of 200 cells per cubic mm of blood was the 
cutoff for disease progress, indicating a damaged immune system. In addition, clinic 
appointment attendance was abstracted for the six months prior to the date of survey 
completion. Non-attendance was defined as missing one appointment without 
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cancellation, or rescheduling more than one appointment in the past six months, similar 
to previous of measures of clinic non-attendance (e.g., Catz, McClure, Jones, & 
Brantley, 1999). Participants’ current (active) medications were also assessed to 
confirm antiretroviral regimen and to determine the presence of co-morbid health 
conditions. Total number of active medications was used as a proxy measure of the 
burden of co-occurring medical conditions. 
 
Data Analytic Strategy 
 Prior to analysis, all data was cleaned and checked for technical or 
computational errors. All analyses were done in SPSS version 21. Descriptive analyses 
were carried out to assess the distribution of study variables and to describe the sample. 
Correlation analyses were also conducted to examine relationships between 
demographic and health variables in the sample. Frequency and descriptive analyses 
were used to describe endorsement of experiences on the enacted stigma checklist that 
was developed for this study. 
 Consistent with the literature on enacted stigma and discrimination (e.g., Bogart, 
et al., 2013), not all participants endorsed an experience of enacted stigma in the past 
year. Chi-square comparisons for categorical variables and F tests for continuous 
variables were used to assess group differences between participants who endorsed an 
enacted stigma event in the past year (n=96) compared to those who denied 
experiencing any events in the past year (n=103).  
 The remainder of analyses was carried out on the sample of participants who 
endorsed experiencing enacted stigma in the past year. Bivariate analyses were used to 
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determine relationships between demographic variables and outcome variables (i.e., 
stress, coping, health indicators) to identify control variables to be used in analyses. 
Correlations were also examined between stigma, stress, coping, and health variables. 
 Finally, multivariate analyses were used to examine the relationships between 
each predictor variable in the path model and health outcome variables. We started by 
conducting a series of linear and logistic regression analyses to evaluate the 
relationship between predictors and health outcomes. Next, the hypothesized study 
model was tested using path analysis via Preacher and Hayes regression-based 
PROCESS tool (Model 14 with 2 mediators and 1 moderator; Hayes, 2013). 
Dichotomous medication adherence was the outcome variable in the path analysis 
given the precedent in the literature described in the introduction. Bootstrapping was 
used to test for effects without assuming normality in the sampling distribution 
(MacKinnon, Lockwood, Hoffman, West, & Sheets, 2002). 
 
Results 
Description of socio-demographic characteristics 
 Participants included a total of 199 men and women. A description of the study 
sample’s demographic information can be found in Table 1. Participants ranged in age 
from 18 to 77 years old, with a mean age of 45.7 (SD: 12.0). A majority of the sample 
identified as male (62%). Nine individuals (5%) identified as transgender. A large 
majority identified their race as African American/Black (84%); 13% identified as White, 
1% Hispanic or Latino, 2% as biracial or multiracial, and 1% identified as ‘Other.’  A 
relative majority identified their sexuality as heterosexual (56%), 30% identified as 
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homosexual, and 11% identified as bisexual. Most participants identified their religion as 
Christian (75%). Most of the sample reported completing high school or beyond (77%), 
and 23% reported not completing high school. In terms of employment, 13% were 
working full-time, 10% part-time, 40% were on disability, 35% were unemployed, and 
3% were students. A total of 100 participants (50%) endorsed a history of incarceration. 
Participants represented 34 unique zip codes, traveling between approximately 0 
and 73 miles to the clinic (M=19.6 ± 14.0). A total of 34 participants (17%) reported 
having unreliable transportation (i.e., could not get to the clinic or to a place to get meals 
because they did not have a ride) in the past month. A total of 23 participants (12%) 
reported having unstable housing (i.e., did not have a place to stay or worried about 
having a place to stay) in the past month. Also, in the past month, 59 participants (30%) 
endorsed having insufficient food (i.e., chose between spending money on medicine or 
food, ran out of food, ran out of money for food or could afford enough food, or ate less 
than needed because there was not enough food).  
 
Health and Medical Characteristics 
Self-reported health information. Health-related characteristics of the sample 
are reported in Table 2. Participants had been living with HIV for an average of 13.5 
years (SD: 8.7, range: 0-36 years). Only 13 participants (7%) reported that they 
attended an HIV support group in the past month. The vast minority of the sample, 4% 
(n=9) reported not currently taking antiretroviral medications. On a visual analog scale, 
participants reported taking 85.7% (SD: 26.3, range: 0-100%) of their medications in the 
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past month on average. Nearly half (42%) of the sample reported that they had made 
attempts to hide their antiretroviral medications in the past month. 
In terms of psychological health, the mean score on the CES-D was 15.6 (SD: 
11.5, range: 0-52), slightly below the recommended clinical cutoff for possible 
depressive symptoms suggested by Radloff and colleagues (1977). A total of 79 
participants (40%) met or exceeded the clinical cutoff of 16 indicating possible clinical 
depressive symptoms. By increasing the clinical cutoff to 23, indicating probable 
depression, 48 participants (24%) met or exceeded the cutoff. On the cognitive/affective 
items, the mean score was 8.3 (SD: 6.4). Only 23 participants (12%) reported they had 
seen a mental health counselor in the past month. 
On the AUDIT total scores were considerably variable with a mean of 3.6 (SD: 
5.4, range: 0-33), and 75 participants reported never drinking alcohol in the past year. A 
total of 34 participants (18%) met or exceeded the clinical cutoff of eight, suggesting 
problematic alcohol use. Only 12 participants (6%) reported they had seen a substance 
use counselor in the past month, and 27 participants (14%) endorsed attending 
Alcoholics Anonymous/Narcotics Anonymous groups in the past month. 
Chart abstracted health data. According to clinic appointment attendance data, 
approximately half (54%) of the participants attended all of their scheduled 
appointments in the past six months, while 46% missed an appointment or cancelled 
more than one appointment. The modal number of appointments scheduled in the past 
six months was 3 (range: 2-5). The average number of active medications listed in 
participants’ charts was 5.6 (SD: 3.8), including an average of 1.9 (SD: 1.2) HIV 
medications and 3.7 (SD: 3.4) medications for other conditions. Viral load data showed 
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that 64% of the sample had an undetectable viral load. Only 10% of the sample had a 
CD4 cell count below 200 cells per cubic millimeter of blood, indicating a significantly 
impaired immune system. 
Co-occurring health conditions were estimated by active medications listed in 
participants’ medical records. Nearly half of the sample received treatment for 
cardiovascular/cerebrovascular conditions (n=97, 49%). A total of 74 individuals (37%) 
were receiving treatment for co-occurring infections (bacterial, viral, or fungal). 
Psychotropic medications were the next most common active medications among 
approximately one third of the participants (n=66; 33%); with 58 participants (29%) 
prescribed antidepressant treatment. The next most common active medication was 
pain treatment among 25% (n=50) of the sample.  
Description of stigma experience 
 The mean score on the internalized stigma subscale was 2.4 (SD: 1.2, range 1-5). 
This score indicated that participants tended to disagree or feel uncertain that they had 
internalized HIV stigma. A total of 96 (48%) participants endorsed experiencing at least 
one event of enacted stigma in the past year. A full description of the enacted stigma 
measure can be found in Table 3. On average, participants reported experiencing 
between two and three different types of enacted stigma events (range: 0-20). They 
endorsed being treated differently by people most (31%), followed by being rejected by 
a potential sexual or romantic partner (23%). Events with the least frequency of 
endorsement were having one’s personal property stolen or damaged (2%), and being 
physically assaulted or beaten (3%).   
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 Descriptive data regarding the enacted stigma events participants selected as 
the most impactful in the past year are show in Table 4. Participants tended to 
experience a moderate level of stress (M: 4.8, SD: 3.3) in reaction to the most impactful 
enacted stigma event. Averaging stress across all items showed relatively low, but 
variable ratings of the negative impact of enacted stigma events in the past year (M: 1.5, 
SD: 2.0, Range: 0-8.8). The frequency of events rated as most impactful ranged from 
about once in the past year (38%), a few times in the past year (23%), a few times per 
month (8%), at least once a week (4%), to almost everyday (19%). 
 When comparing between groups of participants who endorsed experiencing 
enacted stigma in the past year versus those who did not endorse experiencing an 
event (Table 5), they did not differ significantly on any demographic variables. People 
who endorsed enacted stigma in the past year were more likely to have food 
insufficiency (2(2, N=199)=15.2, p<.001). Comparisons among health and medical 
variables are shown in Table 6. Groups differed in that those who endorsed an event of 
enacted stigma in the past year had higher levels of depression (F(1, 190)=10.1, 
p=.002); they scored higher on the AUDIT (F(1, 195)=7.1, p=.008), and they had higher 
internalized HIV stigma (F(1, 195)=13.7, p<.001). 
 
Brief COPE factor analysis 
 As recommended by Carver (1997), the present data were used to identify 
categories of coping using the Brief COPE in the population of interest. A Principal 
Component Analysis was conducted with a Varimax rotation. The 14 scales of the Brief 
COPE were entered as variables rather than using individual items. Correlations 
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between the 14 subscales are presented in Table 7. The cutoff for factor loadings was 
set to .50 as recommended by Comrey and Lee (1992). The factor analysis yielded 3 
factors with Eigenvalues greater than 1 that accounted for 61% of the total variance. 
The 3-factor structure with factor loadings is shown in Table 8. Based on the factor 
structure, the 3 factors are described as follows: maladaptive coping (Denial, Substance 
use, Behavioral disengagement, Venting, Humor, Self-blame; accounting for 22% of 
total variance), adaptive cognitive coping (Self-distraction, Active coping, Positive 
reframing, Planning, Acceptance; 22% of total variance), and adaptive supportive 
coping (Emotional support, Instrumental support, Religion; accounting for 17% of total 
variance). These factors align with other published factor analyses of the Brief COPE 
with populations affected by HIV (Prado, et al., 2004). Composite scores were 
calculated for each of the coping factors. Given that the proposed model for this study 
included adaptive coping as one variable, the adaptive cognitive coping and supportive 
coping were combined into one variable composite score for analysis. A description of 
Brief COPE subscales and factors in reaction to the most impactful event of enacted 
HIV stigma in the past year is shown in Table 9. The approaches to coping that were 
endorsed most frequently in this sample included acceptance, religious coping, and 
positive reframing.  
 
Bivariate Analyses  
Exploratory correlation analyses in the full sample. Correlations were first 
examined among sociodemographic and mental and physical health variables in the full 
sample to confirm validity of measures (e.g., medication adherence self-report measure 
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was associated with viral load abstracted from medical record). Correlations are shown 
in Table 10. Measures of internalized and enacted stigma were positively correlated (r=-
0.36, p<.001). Internalized stigma was related to both depressive symptoms (r=-0.43, 
p<.001) and alcohol use (r=-0.21, p=.003); while enacted stigma related only to 
depressive symptoms (r=-0.36, p<.001). Internalized stigma was negatively correlated 
with total number of active medications (r=-0.14, p<.05). Viral load detectability was 
negatively related VAS medication adherence (r=-0.32, p<.001) and viral load status 
related to immune functioning (=0.25, p=.001) as expected. 
Relationships between sociodemographic characteristics and outcomes. 
Correlations between demographic and study variables were examined first to 
determine which demographic variables to control for in multivariate analyses (Table 11). 
Employment (working vs. not working) was associated with stress related to the most 
impactful enacted stigma event in the past year (r=-0.21, p=.05). Employment was also 
associated with maladaptive coping (r=-0.28, p<.01). Age (r=0.44, p<.01), years since 
HIV diagnosis (r=0.38, p<.01), gender (r=0.25, p=.01), and employment (r=-0.32, p<.01)  
were all associated with total number of active medications. Gender (=-0.22, p=.03), 
sexual minority status (=0.26, p=.01), and unstable housing (=0.26, p=.01) all related 
to viral load (detectable vs. undetectable). Education attainment was associated with 
having a CD4 cell count below the threshold of 200 (r=-0.23; p=.03). Significant 
covariates were controlled for in analyses of respective outcome variables (e.g., 
education was controlled for when CD4 cell count was the outcome variable). 
Relationships among study variables. As expected, internalized stigma was 
significantly correlated with stress indexed on enacted stigma (r=0.37, p<.01), 
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maladaptive coping (r=0.47, p<.01), and adaptive coping (r=0.24, p=.02). Stress 
associated with the most impactful event of enacted stigma was positively associated 
with both maladaptive (r=.31, p<.01) and adaptive coping (r=0.25, p=.02). Among the 
health variables, medication adherence was significantly related to viral load (=-0.30, 
p<.01), viral load status was correlated with CD4 cell count (=0.24, p=.02), and total 
number of active medications was also related to CD4 cell count (r=0.27, p<.01). 
Multivariate relationships of HIV stigma on health 
 Individual regression analyses were conducted to examine the relationships 
between study variables and HIV-related health outcomes. Results from linear and 
logistic regression analyses are presented in Table 12. First the relationships between 
the independent variable (internalized stigma), proposed mediator variables (stress and 
maladaptive coping), and moderator variable (adaptive coping) were examined. 
Internalized HIV stigma significantly predicted stress associated with the most impactful 
event of enacted stigma B(SE)=0.92(0.26), p=.001; maladaptive coping 
B(SE)=0.55(0.11), p<.001; and adaptive coping B(SE)=0.29(0.12), p=.02. The only 
health outcome predicted by internalized HIV stigma was CD4<200 AOR=2.15(0.11), 
95% CI [1.04-4.46], p=.04. 
 Path analysis with bootstrapping was used to test the proposed study model. 
Results of the path analyses are presented in Table 13 and are reported in 
unstandardized form to promote interpretation based on the metrics used in the study. 
Variables at the front of the hypothesized model were significantly related, as can be 
seen in Figure 2. Specifically, internalized HIV stigma predicted stress associated with 
an impactful enacted stigma event in the past year (path a =.917, p<.001, 95% CI [0.39-
 27 
1.44]). Internalized HIV stigma also predicted maladaptive coping strategies used to 
cope with enacted stigma in the past year (path b =.571, p<.001, 95% CI [0.34-0.0.80]). 
However, there was no evidence that internalized HIV stigma, stress, or maladaptive 
coping predicted medication adherence. Thus mediation of the relationship between 
internalized stigma and medication adherence was not present. Additionally, there was 
no evidence for moderation by adaptive coping strategies.  
 
Discussion 
The present study examined the relationships between HIV-related stigma and 
health outcomes in a sample of PLWH attending clinic appointments in middle Georgia. 
Specifically, we examined the effect of HIV stigma though the mechanisms of stress 
related to a recent, salient enacted stigma experience and efforts to cope with that 
event. A recent meta-analysis pointed out the lack of literature investigating the 
mechanisms and attenuating factors involved in the relationship between stigma and 
health outcomes (Rueda, et al., 2016). The present investigation sought to add to the 
growing body of research filling that gap.  
Endorsement of HIV stigma was relatively low in this sample and aligned with 
previous investigations of HIV stigma in populations living in other geographic areas in 
the United States (Bogart, et al., 2013; Earnshaw, et al., 2013; Chaudoir, et al., 2012; 
Vanable, Carey, Blair, & LIttlewood, 2006). Overall, internalized stigma was reported in 
the moderate to low range and approximately half the sample did not endorse an 
experience of enacted stigma in the past year. One might expect that every person 
living with HIV experiences HIV stigma. However, there are many reasons this may not 
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be the case. Many individuals living with HIV do not disclose their HIV status to others, 
which limits the opportunities for enacted stigma to occur. Unfortunately, this same 
process may contribute to individuals not seeking the medical support they need or 
attend clinic appointments at all. Disclosure was not assessed in this study so no 
conclusions can be drawn about the relationship between openness about HIV status 
and enacted stigma. Moreover, PLWH typically have other stigmatized characteristics 
(e.g., race, gender, sexual preference), which take precedence over their HIV status or 
interact with HIV-related stigma (Bogart, et al., 2013). Individuals who endorsed enacted 
stigma in the past year reported moderate levels of subjective stress associated with 
salient stigmatizing events, and they endorsed using several different approaches to 
coping with enacted stigma. Acceptance, religious coping, and positive reframing were 
the most frequently endorsed coping strategies for enacted stigma events in this sample. 
Individuals who endorsed enacted stigma in the past year were more likely to have 
greater food insecurity, symptoms of depression, alcohol abuse, and internalized HIV 
stigma compared to individuals who did not endorse enacted stigma in the past year. 
While these comparative findings may corroborate the literature linking HIV stigma to 
poorer mental health outcomes among PLWH, study hypotheses were tested to 
examine the relationships between HIV stigma and physical health outcomes in this 
sample.  
The first hypothesis predicted a negative relationship between internalized HIV 
stigma and HIV-related health outcomes. Among the health outcomes in this study, 
higher levels internalized HIV stigma was associated with greater HIV disease 
progression based on a CD4 threshold indicating a compromised immune system (CD4 
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< 200). This finding suggests that internalization of stigma is heightened when overt 
symptoms of disease present and people can no longer control disclosure of their HIV 
status. In this sample, internalized HIV stigma did not significantly predict medication 
adherence, viral suppression, clinic attendance, or number of active medications.  
The second study hypothesis predicted co-mediating effects of stress indexed on 
a salient enacted stigma event and maladaptive coping strategies on the relationship 
between internalized stigma and HIV-related health outcomes, specifically medication 
adherence. Internalized stigma was significantly related to stress indexed on enacted 
stigma, such that every one-unit difference in internalized stigma conferred a .917 
difference in stress. Internalized stigma also predicted maladaptive coping such that 
one unit difference in stigma conferred a .571 difference in maladaptive coping. 
However, neither of these paths mediated the relationship between internalized stigma 
and health behavior, medication adherence in this case. 
The final study hypothesis predicted a moderating effect of adaptive and 
supportive coping strategies on the relationship between internalized HIV stigma and 
health. Once again, there was not evidence in this sample supporting the moderating 
role of adaptive and supportive coping resources on HIV-related health outcomes. 
There are several potential reasons for the lack of statistically significant effects 
found for internalized HIV stigma, stress, and coping resources on medication 
adherence. First, stress and coping were indexed on a single, salient event of enacted 
stigma in the past year. This may have limited the range of stressful experiences as well 
as the compounding effects of multiple stigmatizing events in the past year and beyond 
that time frame. It is possible that internalized and enacted stigma have short-term 
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effects on mental health outcomes such as depressive symptoms and alcohol use. 
Effects on physical health may compound over time and take longer to show significant 
effects, especially when considering stigma as a chronic stressor in the lives of people 
who are stigmatized. On the other hand, directionality of these relationships cannot be 
determined from this study. Individuals with poorer mental health may be more sensitive 
to HIV stigma. A next step for research in this area should make use of prospective and 
longitudinal data to parse out the directions of these relationships. 
Other contextual factors likely contribute to the impact of HIV stigma on health. 
One could contextualize stigma in an ecological framework of health (Whetten-
Goldstien & Pence, 2013), which widens the potential mechanisms at the individual, 
environmental, and systemic levels. Indeed, in a recently published study, authors 
hypothesized that interpersonal factors contribute to the impact of HIV stigma on 
medication adherence given the interpersonal nature of stigma (Helms, et al., 2016). 
They found that attachment-related anxiety and concern with being seen while taking 
ART medications influenced the relationship between stigma and adherence. The 
present study exclusively examined intrapersonal factors of stress and coping as they 
impact the relationship between HIV stigma and health and may have limited effects. 
A few study limitations are worth noting. The cross-sectional approach to the 
present data analysis is a chief limiting factor. Cross sectional data limits the 
interpretation of mediated and moderated relationships and directionality of 
relationships cannot be determined. Future research could follow participants 
longitudinally to assess the effect of HIV-related stigma and its mechanisms on health 
among PLWH over time. Second, levels of stigma were relatively low in this sample. 
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While the relatively low endorsement of stigma may be consistent with previous findings 
in the literature (e.g., Bogart, et al., 2013; Earnshaw, et al., 2013; Chaudoir, et al., 2012; 
Vanable, Carey, Blair, & LIttlewood, 2006), it did limit power in conducting analyses in 
this study. Given that low endorsement of internalized and enacted stigma may be 
expected, larger samples should be recruited in future investigations in order to 
increase power in statistical tests. 
Enacted stigma in the past year was assessed exclusively based on HIV-positive 
status. Intersectionality and layering of different types of stigmatized identities (e.g., 
race-based, sexual orientation, mental health and substance use, socioeconomic 
status) are very likely to impact health in this population. Stigma based on HIV status 
was accounted for in this study to fully understand the mechanisms of HIV-related 
stigma in a population of PLWH living in the rural south. However, this may be too 
narrow a focus and the wider interpersonal and intrapersonal context should also be 
considered. Future research could expand on these findings to account for other types 
of discrimination, or ask participants which form of discrimination is most salient in their 
lives. Mixed methods approaches may also be a valuable avenue for understanding the 
nuances by which HIV-related stigma influences PLWH psychologically. 
Finally, the present study sample was one that was engaged in care at a 
specialty HIV clinic. Consequently, conclusions cannot be drawn about the role of HIV-
related stigma and discrimination among people who have not engaged in care or who 
have lapsed in their HIV care for more than six months. One could assume that 
individuals not engaged or lapsed in care are likely most afflicted by HIV-related stigma. 
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Some thought should be given to how to engage these individuals in future research as 
well as medical care. 
 In spite of these limitations, this is one of few studies to exclusively assess the 
role of HIV-related stigma on health outcomes, through the mechanisms of stress and 
specific coping strategies indexed on recent events of enacted HIV stigma. This 
approach created a fuller understanding of specific enacted stigma experienced by 
PLWH living in a low resource area in the Southeast. Another strength is the use of 
chart information rather than relying exclusively on self-report for health outcomes of 
interest.  
 
Conclusions 
 The present study examined the experience of HIV stigma in a sample of PLWH 
residing in middle GA and receiving medical care at a Ryan White clinic. It also sought 
to examine the mechanisms by which HIV stigma relates to health outcomes in this 
population. While strong relationships were found between internalized stigma, enacted 
stigma, stress, and coping; together these mechanisms did not translate to significant 
health outcomes in this sample. It is possible that focusing on specific experiences of 
enacted HIV stigma limited effects by not accounting for the compounding, chronic 
stress of stigma. It is also possible that focusing exclusively on HIV stigma did not 
account for the wider context of other stigmatized identities or the intersectionality of 
stigma on health outcomes. Future research should focus on prospective and 
longitudinal studies to explore the mechanisms of the effects of stigma on health in 
PLWH. Qualitative investigations may also be useful to understand the nuanced effects 
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of stigma in the lives of PLWH for which quantitative studies are not sensitive enough to 
uncover. From a clinical perspective, individuals who endorsed experiences of enacted 
HIV stigma in the past year tended to have greater psychosocial and mental health 
concerns. Symptoms of depression and alcohol use likely translate to poorer physical 
health over time. From a clinical intervention perspective, HIV stigma is an important 
piece of the context of health disparities for PLWH and should be attended to in 
interventions. Based on the moderate level of endorsement of HIV stigma in this sample 
and others, individuals may not be motivated to participate in an intervention focused 
specifically on stigma. But, clinicians and researchers can potentially improve mental 
health outcomes by including material specific to HIV stigma so that PLWH can feel in 
control of their reactions to such experiences and fully utilize their coping resources. 
Comprehensive assessments of stigma in this population may be useful to determine 
areas that can be targeted in intervention. Moreover, health interventions implemented 
in HIV care settings, such as stress management or medication adherence or 
adjustment to HIV, could include material specific to managing HIV stigma. Clinical 
intervention researchers may add to these efforts by assessing the acceptability of 
stigma-related content in addition to the comparative effectiveness of interventions 
containing stigma-related content compared to traditionally-implemented therapeutic 
interventions.  
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Table 1. Descriptive statistics of socio-demographic characteristics, full sample (N=199). 
Characteristic n (%)  
Age (M ± SD, range) 45.7 ± 12.0, 18-77 
Gender  
     Male 123 (62%) 
     Female 74 (37%) 
     Transgender 9 (5%) 
Race  
     African American/Black 167 (84%) 
     White 25 (13%) 
     Hispanic Latino 2 (1%) 
     Biracial or Multiracial 3 (2%) 
     Other 2 (1%) 
Sexual Orientation  
     Homosexual/Same sex loving 59 (30%) 
     Bisexual 22 (11%) 
     Heterosexual/Straight 112 (56%) 
Education Level  
     Less than HS degree 45 (23%) 
     HS degree or equivalent 70 (35%) 
     More than HS degree 84 (42%) 
Employment  
     Working full time 26 (13%) 
     Working part time 19 (10%) 
     On disability 79 (40%) 
     Unemployed 69 (35%) 
     Student 5 (3%) 
Religion  
     Christian 148 (75%) 
     Agnostic/Atheist  2 (1%) 
     Spiritual but not religious 20 (10%) 
     Other 28 (14%) 
Ever incarcerated 100 (50%) 
In the past month:  
     Unreliable Transportation 34 (17%) 
     Unstable Housing 23 (12%) 
     Insufficient Food 59 (30%) 
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Table 2. Health and medical characteristics of full sample (N=199). 
Characteristic M ± SD, range, or n(%) 
Years since HIV Diagnosis  13.5 ± 8.7, 0-36 
Taking ARVs (self-report) 190 (96%) 
Visual analog medication adherence  85.7 ± 26.3, 0-100 
Medication adherence > 85% 144 (72%) 
# Active medications 5.6 ± 3.8 
     # Antiretroviral medications 1.9 ± 1.2 
     # non-HIV medications 3.7 ± 3.4 
Clinic attendance past 6 months:  
     Missed appointments  91 (46%) 
     Attended all appointments 108 (54%) 
Most recent viral load 2432.5 ± 11517.4 
Viral Load Status:  
     Detectable (≥20 copies/mL) 66 (33%) 
     Undetectable  127 (64%) 
Most recent CD4 count 575.4 ± 307.3 
CD4 cell count < 200 19 (10%) 
CESD  15.6 ± 11.5, 0-52 
AUDIT  3.6 ± 5.4, 0-33 
In the past month:  
     Mental health counselor 23 (12%) 
     Substance use counselor 12 (6%) 
     AA/NA meeting 27 (14%) 
     HIV support group 13 (7%) 
Health-related quality of life past month:  
     General health  “good” 163 (82%) 
     Health not good  2 weeks 63 (32%) 
     Health kept from activities  2 weeks 50 (25%) 
     Pain  2 weeks 56 (28%) 
Comorbid treatment:  
     Pulmonary treatment 36 (18%) 
     Diabetes treatment 18 (9%) 
     Hepatitis C treatment 2 (1%) 
     Infection treatment 74 (37%) 
     Cardiovascular treatment 97 (49%) 
     Gastrointestinal treatment 34 (17%) 
     Pain treatment  50 (25%) 
     Urinary/prostate treatment 6 (3%) 
     Thyroid treatment  6 (3%) 
     Psychotropic treatment 66 (33%) 
     Sleep aid 7 (4%) 
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Table 3. Enacted stigma item endorsement. 
In the past year… n (%) 
  People have treated me differently 61 (31%) 
  Family members have avoided me 23 (12%) 
  Family members have looked down on me 26 (13%) 
  Community/social workers have discriminated against me 22 (11%) 
  Healthcare workers have avoided touching me 17 (9%) 
  I have lost friends by telling them I have HIV 29 (15%) 
  People seem afraid of me 32 (16%) 
  People have physically backed away from me 35 (18%) 
  People who know I have HIV ignore my good points 35 (18%) 
  People don’t want me around their children 28 (14%) 
  I have been treated with hostility or coldness by strangers 27 (14%) 
  I have been ignored, excluded or avoided by people close to me 29 (15%) 
  I have been rejected by a potential sexual or romantic partner 45 (23%) 
  Someone acted as if I could not be trusted 25 (13%) 
  I was denied a place to live or lost a place to live 9 (5%) 
  I was treated poorly or made to feel inferior when receiving healthcare 18 (9%) 
  I was denied a job or lost a job 12 (6%) 
  Someone insulted or made fun of me 28 (14%) 
  My personal property was damaged or stolen 3 (2%) 
  I was physically assaulted or beaten 5 (3%) 
Range # events endorsed in the past year 0 - 20 
Mean # events endorsed in the past year  M: 2.6 (SD: 4.3) 
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Table 4. Enacted stigma item selected as most impactful in the past year. 
In the past year… n (%) 
  People have treated me differently 20 (10%) 
  Family members have avoided me 4 (2%) 
  Family members have looked down on me 5 (3%) 
  Community/social workers have discriminated against me 0 (0%) 
  Healthcare workers have avoided touching me 3 (2%) 
  I have lost friends by telling them I have HIV 5 (3%) 
  People seem afraid of me 3 (2%) 
  People have physically backed away from me 2 (1%) 
  People who know I have HIV ignore my good points 3 (2%) 
  People don’t want me around their children 3 (2%) 
  I have been treated with hostility or coldness by strangers 3 (2%) 
  I have been ignored, excluded or avoided by people close to me 3 (2%) 
  I have been rejected by a potential sexual or romantic partner 17 (9%) 
  Someone acted as if I could not be trusted 3 (2%) 
  I was denied a place to live or lost a place to live 1 (1%) 
  I was treated poorly or made to feel inferior when receiving healthcare 4 (2%) 
  I was denied a job or lost a job 4 (2%) 
  Someone insulted or made fun of me 5 (3%) 
  My personal property was damaged or stolen 0 (0%) 
  I was physically assaulted or beaten 0 (0%) 
  
Stress associated with most impactful event M: 4.8 (SD: 3.3) 
Composite stress score M: 1.5 (SD: 2.0) 
Frequency, past year, most impactful event  
  Almost everyday 18 (9%) 
  At least once a week 4 (2%) 
  A few times a month 8 (4%) 
  A few times this year 22 (11%) 
  About once this year 36 (18%) 
  Never (denied any events in the past year) 103 (52%) 
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Table 5. Comparisons of sociodemographic characteristics between groups – participants who 
endorsed enacted stigma in past year versus those who did not. 
 
 
Characteristic 
Endorsed event 
past year  
(n= 96) 
Did not endorse 
event past year 
(n= 103) 
Between Group 
Comparison 
(F or χ2 p value) 
Age 44.9 ± 12.5 46.5  ± 11.6 .353 
Gender   .429 
     Male 62 61  
     Female 33 41  
     Transgender 5 4  
Race   .582 
     African American/Black 78 89  
     White 13 12  
     Hispanic or Latino 1 1  
     Biracial or Multiracial 2 1  
     Other 2 0  
Sexual Orientation   .462 
     Homosexual/Same sex loving 28 31  
     Bisexual 13 9  
     Heterosexual/Straight 50 62  
Education Level   .691 
     Less than HS degree 22 23  
     HS degree or equivalent 31 39  
     More than HS degree 43 41  
Employment   .791 
     Working full time 13 13  
     Working part time 7 12  
     On disability 38 41  
     Unemployed 34 35  
     Student 3 2  
Religion   .246 
     Christian 71 77  
     Agnostic/Atheist  2 0  
     Spiritual but not religious 12 8  
     Other 11 17  
Ever incarcerated 52 48 .286 
In the past month:    
     Unreliable transportation 18 16 .547 
     Unstable housing 14 9 .197 
     Food insufficiency 41 18 <.001* 
     Mental Health Counselor 13 10 .709 
     Substance Use Counselor 9 3 .187 
     HIV Support Group 11 2 .103 
     AA/NA Groups 18 9 .634 
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Table 6. Comparisons of health and medical information between groups endorsing events of 
enacted stigma in the past year.  
 
 
Characteristic 
Endorsed event 
past year (n= 96) 
Did not endorse 
event past year 
(n= 103) 
Between Group 
Comparison 
(F or χ2 p value) 
Years since HIV Diagnosis  13.2 ± 8.8 13.7 ± 8.7 .698 
CESD score 18.3 ± 12.3 13.1 ± 10.2 .002* 
CESD cognitive/affective 9.8 ± 6.7 6.8 ± 5.9 .001* 
AUDIT 4.7 ± 6.5 2.7 ± 4.0 .008* 
Internalized stigma 2.7 ± 1.2 2.1 ± 1.0 <.001* 
Visual analog med adherence  86.2 ± 26.8 85.3 ± 26.0 .822 
# Active medications 5.2 ± 3.5 6.0 ± 4.1 .113 
Most recent viral load   .509 
Most recent CD4 count 575.4 ± 278.4 575.4 ± 334.4 1.00 
    
Quality of Life Measures    
     General health  “good” 77 (80%) 86 (83%) .311 
     Health not good  2 weeks 37 (39%) 26 (25%) .098 
     Health kept from activities     
      2 weeks 
33 (34%) 17 (17%) .021* 
     Pain  2 weeks 33 (34%) 23 (22%)  .067 
    
Clinic attendance   .589 
     Missed appointments  42 (44%) 49 (48%)  
     Attended all 54 (56%) 54  (52%)   
Viral Load Status   .515 
     Detectable (≥20) 30 (31%) 36 (35%)  
     Undetectable  64 (67%) 63 (61%)  
CD4 cell count < 200 7 (7%) 12 (12%) .256 
    
Comorbid treatment    
     Pulmonary treatment 16 (17%) 20 (19%) .614 
     Diabetes treatment 6 (6%) 12 (12%) .184 
     Hepatitis C treatment 2 (2%) 0 (0%) .141 
     Infection treatment 33 (34%) 41 (43%) .428 
     Cardiovascular treatment 43 (45%) 54 (52%) .282 
     Gastrointestinal treatment 10 (10%) 24 (23%) .016* 
     Pain treatment  23 (24%) 27 (26%) .714 
     Urinary/prostate treatment 2 (2%) 4 (4%) .458 
     Thyroid treatment  4 (4%) 2 (2%) .359 
     Psychotropic treatment 34 (35%) 32 (33%) .515 
     Sleep aid 2 (2%)  5 (5%) .289 
Note: Significant group differences denoted with a *. 
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Table 7. Correlations between coping subscales (N=96). 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Self 
Distraction 
---              
2. Active  .395 
** 
---             
3. Denial  .428 
** 
.435 
** 
---            
4. Substance 
Use  
.368 
** 
.198 
+ 
.411 
** 
---           
5. Emotional 
Support 
.350 
** 
.448 
** 
.411 
** 
.174 
+ 
---          
6. Instrumental 
Support 
.363 
** 
.425 
** 
.434 
** 
.337 
* 
.735 
** 
---         
7. Behavioral 
Disengagement 
.263 
* 
.263 
* 
.592 
** 
.464 
** 
.301 
* 
.390 
** 
---        
8. Venting .443 
** 
.419 
** 
.577 
** 
.295 
* 
.436 
** 
.540 
** 
.543 
** 
---       
9. Positive 
Reframe 
.415 
** 
.529 
** 
.387 
** 
.351 
** 
.422 
** 
.348 
* 
.399 
** 
.343 
* 
---      
10. Planning .489 
** 
.610 
** 
.426 
** 
.283 
* 
.616 
** 
.540 
** 
.478 
** 
.473 
** 
.662 
** 
---     
11. Humor  .170 .218 
* 
.334 
* 
.358 
** 
.250 
* 
.259 
* 
.328 
* 
.464 
** 
.261 
* 
.354 
** 
---    
12. Acceptance .501 
** 
.326 
* 
.269 
* 
.202 
* 
.363 
** 
.276 
* 
.196 
+ 
.410 
** 
.345 
* 
.501 
** 
.173 
+ 
---   
13. Religion  .180 
+ 
.163 .289 
* 
.086 .487 
** 
.430 
** 
.287 
* 
.362 
** 
.354 
** 
.445 
** 
.253 
* 
.427 
** 
---  
14. Self Blame .343 
* 
.209 
* 
.329 
* 
.458 
** 
.248 
* 
.373 
** 
.529 
** 
.481 
** 
.235 
* 
.420 
** 
.439 
** 
.256 
* 
.244 
+ 
--- 
Note: p<.001**; p<.05*; p<.10+ 
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Table 8. Principal component analysis with varimax rotation of three-factor structure of the Brief 
COPE (N= 96). 
 
Subscale 1 2 3 
Denial .579 .392 .218 
Substance Use .721 .319 -.165 
Behavioral Disengagement .751 .186 .196 
Venting .580 .307 .427 
Humor .653 .011 .246 
Self-Blame .745 .115 .168 
Self-Distraction .259 .745 .022 
Active Coping .110 .738 .207 
Positive Reframing .232 .714 .205 
Planning .277 .659 .467 
Acceptance .075 .580 .328 
Emotional Support .129 .389 .754 
Instrumental Support .326 .304 .669 
Religion .141 .107 .792 
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Table 9. Descriptive statistics of Brief COPE subscales in response to coping with most 
impactful enacted stigma event in the past year (N = 96). 
Brief COPE Subscale M SD 
Denial Coping 3.97 2.09 
Substance Use Coping 3.57 2.06 
Behavioral Disengagement Coping 3.64 1.93 
Venting Coping 4.16 2.16 
Humor Coping 3.47 1.91 
Self Blame Coping 4.03 2.00 
Self Distraction Coping 4.58 2.14 
Active Coping 4.70 2.17 
Positive Reframe Coping 5.03 2.08 
Planning Coping 4.55 2.06 
Acceptance Coping 5.51 1.91 
Emotional Support Coping 4.31 2.08 
Instrumental Support Coping 4.11 2.02 
Religion Coping 5.32 2.21 
Coping Factors   
Maladaptive Coping composite score 3.80 1.48 
Cognitive Adaptive Coping composite score 4.86 1.58 
Supportive Coping composite score 4.58 1.76 
Adaptive Cognitive + Supportive Coping composite score 4.75 1.49 
 Note: Range of subscales is 2-8. 
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Table 10. Correlations between sociodemographic and mental and physical health variables in full sample (N=199). 
 CESD AUDIT Internalized 
Stigma 
Enacted 
Stigma 
Clinic 
Attendance 
Total # 
medications 
VAS 
Adherence 
VL>20 CD4 
<200 
Age 
 
-.064 -.059 -.207* -.025 -.178* .462** .143+ -.151* .061 
Gender 
 
.135+ -.089 .075 -.015 .151* .168* .027 -.095 .035 
Sexual 
minority 
-.036 .033 -.106 -.160* -.218* -.046 -.001 .174* -.112 
Education 
 
-.111 -.083 -.018 -.126+ .025 -.144* -.036 .103 -.083 
Working 
 
-.232* -.051 -.019 -.144* .067 -.246** -.064 .125 -.105 
Stable 
Housing 
.202* .208* .131+ .065 .075 -.038 -.040 .119 .044 
Food 
insecurity 
.308** .152* .168* .162* .060 .006 -.055 .012 .051 
Years since 
HIV diagnosis 
-.089 -.087 -.210* -.019 -.140 .354** .076 -.095 .004 
CESD 
 
--- .201* .433** .359** .035 .154* -.123+ -.024 .067 
AUDIT 
 
--- --- .209* .133 .074 .029 -.062 .183* .048 
Internalized 
HIV stigma 
--- --- --- .372** -.026 -.142* -.127+ .078 .107 
Enacted HIV 
Stigma 
--- --- --- --- -.001 -.083 -.130+ -.089 .002 
Clinic 
Attendance 
--- --- --- --- --- -.027 -.101 .101 .023 
Total # 
medications 
--- --- --- --- --- --- -.032 -.055 .126* 
VAS 
Adherence 
--- --- --- --- --- --- --- -.321** -.024 
Viral load>20 
 
--- --- --- --- --- --- --- --- .246* 
Note: p<.001**; p<.05*; p<.10+ 
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Table 11. Correlations between sociodemographic variables and outcome variables in path model (N=96). 
 Stress Maladaptive 
Coping 
Adaptive 
Coping 
Clinic 
Attendance 
Total # 
medications 
Med 
Adherence 
(VAS>85%) 
Viral Load 
Status 
(VL>20) 
CD4 
(<200) 
Age -.095 -.067 -.043 -.163 .443** .049 -.037 .140 
Gender .024 .055 .038 .063 .253* .030 -.223 .044 
Racial minority .107 .099 .111 -.011 -.076 -.076 -.056 -.004 
Sexual minority -.049 -.115 -.069 -.179+ -.129 .024 .263* -.096 
Education -.019 .017 -.037 .042 -.120 -.010 .075 -.228* 
Working -.209* -.277* -.098 -.015 -.323* .009 .161 -.157 
Stable Housing .022 .169 .161 .103 -.038 .076 .255* .121 
Years since 
HIV diagnosis 
-.068 -.142 .001 -.102 .381** -.029 -.076 .105 
CESD .395** .429** .172 .001 .214* .009 -.009 .106 
AUDIT .092 .282* .166 .144 .020 -.091 .175+ .085 
Internalized 
HIV stigma 
.366** .473** .242* -.036 .002 -.094 .047 .226* 
Enacted HIV 
Stigma 
.368** .414** .192+ .023 -.058 -.111 -.106 .072 
Stress --- --- --- --- --- --- --- --- 
Maladaptive 
Coping 
.311** --- --- --- --- --- --- --- 
Adaptive 
Coping 
.246* .619** --- --- --- --- --- --- 
Clinic 
Attendance 
.062 -.118 -.080 --- --- --- --- --- 
Total # 
medications 
.094 .149 .037 -.148 --- --- --- --- 
Med 
adherence 
-.024 -.140 -.097 -.020 -.028 --- --- --- 
Viral load>20 .071 -.093 -.096 -.050 -.044 -.300* --- --- 
CD4<200 .140 .063 -.013 -.168 .272* .058 .240* --- 
Note: p<.001**; p<.05*; p<.10+ 
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Table 12. Associations between model mechanisms and HIV-related health outcomes. 
 
 Stress Maladaptive 
Coping 
Adaptive 
Coping 
Number 
Meds 
Clinic 
Attendance 
VAS<85% Viral Load 
Status 
CD4<200 
Internalized 
HIV Stigma 
B(SE)=0.92  
(0.26) 
=0.35 
p=.001 
B(SE)=0.55 
(0.11) 
=0.45 
p<.001 
B(SE)=0.29 
(0.12) 
=0.24 
p=.02 
B(SE) =0.12 
(0.27) 
=0.04 
p=.66 
OR=0.96 
(0.68-1.31) 
p=.72 
OR=0.84 
(0.57-1.23) 
p=.36 
OR=1.00 
(0.66-1.54) 
p=.98 
OR=2.15 
(1.04-4.46) 
p=.04 
Stress --- B(SE)=0.13 
(0.05) 
=0.27 
p=.01 
B(SE)=0.12 
(0.05) 
=0.25 
p=.02 
B(SE)=0.09 
(0.10) 
=0.09 
p=.36 
OR=0.69 
(0.91-1.18) 
p=.56 
OR=0.98 
(0.85-1.14) 
p=.83 
OR=1.09 
(0.93-1.28) 
p=.31 
OR=1.19 
(0.92-1.54) 
p=.20 
Maladaptive 
Coping 
--- --- --- B(SE)=0.33 
(0.23) 
=0.14 
p=.14 
OR=0.85 
(0.64-1.13) 
p=.25 
OR=0.81 
(0.59-1.11) 
p=.18 
OR=0.83 
(0.56-1.22) 
p=.34 
OR=1.21 
(0.73-1.99) 
p=.46 
Adaptive 
Coping 
--- --- --- B(SE)=0.04 
(0.21) 
=0.02 
p=.87 
OR=0.90 
(0.68-1.18) 
p=.44 
OR=0.86 
(0.63-1.18) 
p=.35 
OR=0.82 
(0.58-1.17) 
p=.27 
OR=0.94 
(0.55-1.60) 
p=.83 
Note: standardized betas and regression coefficients with standard errors presented for linear regressions. Odds ratios and 
confidence intervals presented for logistic regressions.  
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Table 13.  Regression analyses among study variables predicting health outcome (VAS<85%). 
 Consequent 
  M1 (Stress)  M2 (Maladaptive Coping)  Y (VAS<85%) 
Antecedent  B SE p  B SE p  B SE p 
X (Internalized 
Stigma) 
a .917 .263 <.001 b .571 .114 <.001 c’ -.175 .254 .492 
M1  --- --- ---  --- --- --- d1 .119 .273 .663 
M2  --- --- ---  --- --- --- d2 -.003 .673 .996 
V (Adaptive 
Coping) 
 --- --- ---  --- --- --- e1 .176 .477 .713 
M1 x V  --- --- ---  --- --- --- e2 -.018 .051 .729 
Constant iM1 2.651 0.840 .002 iM2 2.407 0.364 <.001 iY 1.245 2.218 .575 
  R2=.413  R2=.282   
  F(2, 83)=8.509, p<.001  F(2, 83)=16.310, p<.001   
Note: Employment status was included as covariate. 
 56 
 
Figure 1. Conceptual model adapted for current study to investigate the relationships between 
HIV stigma and HIV health outcome mediated by perceived stress and maladaptive coping 
strategies, with potential buffering effects of adaptive coping resources. 
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Figure 2. Conceptual model tested in current study showing significant association between 
internalized HIV stigma and stress related to most impactful enacted stigma event in the past 
year, as well as maladaptive coping approaches in response to most impactful enacted stigma 
event. Employment status was included as a covariate in analysis. 
 
